
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 561.00 |
| High | 568.75 |
| Low | 543.30 |
| Prev Close | 554.85 |
| Volume | 2,55,741 |
| VWAP(₹) | 554.12 |
| PE Ratio(x) | 31.47 |
| EPS - TTM(₹) | 17.35 |
| MCap(₹ Cr.) | 2,438.95 |
| MCap Rank | 7 |
| PB Ratio(x) | 7.75 |
| Div Yield(%) | 0.37 |
| Face Value(₹) | 2.00 |
| 52W High(₹) | 902.65 |
| 52W Low(₹) | 376.05 |
| MCap/Sales | 3.10 |
| Beta(1 Month) | 2.89 |
| BV/Share(₹) | 71.57 |
Dividend Announcement
Company announced a dividend of Rs 2.0 per share on May 6, 2026 with record date of Jun 18, 2026.Contingent Liabilities Coverage
Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)Quarterly Topline Performance
Company witnessed QoQ revenue growth of 11.48%, which is highest in the last 3 years. (Source: Standalone Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 19.54% outperformed its 3 year CAGR of 9.23%. (Source: Standalone Financials)Vimta Labs Share Price Update
Vimta Labs Ltd. share price moved down by -1.60% from its previous close of Rs 554.85. Vimta Labs Ltd. stock last traded price is 546.00
| Share Price | Value |
|---|---|
| Today/Current/Last | 546.00 |
| Previous Day | 554.85 |
Found Insights useful?
| 1 Day | -1.6% |
| 1 Month | 21.2% |
| 3 Months | 30.5% |
| 1 Year | 6.26% |
| 3 Years | 160.34% |
| 5 Years | 316.4% |
1 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | - | - | - | - |
| Buy | 1 | 1 | 1 | 1 |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 1 | 1 | 1 | 1 |
8 smallcap stocks rally up to 50% after June quarter results day
NSDL IPO: GMP, brokerage view, GMP & other 8 things to know before subscribing
At multi-year highs: Vimta Labs, Laurus Labs among 7 stocks witness 5-year swing high breakout
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcements| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|
| Total Income | 91.15 | 85.43 | 82.45 | 80.18 | 82.57 |
| Total Income Growth (%) | 6.70 | 3.61 | 2.83 | -2.90 | 9.45 |
| Total Expenses | 66.65 | 63.13 | 65.45 | 63.36 | 68.53 |
| Total Expenses Growth (%) | 5.57 | -3.54 | 3.29 | -7.55 | 3.15 |
| EBIT | 24.50 | 22.30 | 17.00 | 16.82 | 14.04 |
| EBIT Growth (%) | 9.88 | 31.16 | 1.10 | 19.76 | 55.94 |
| Profit after Tax (PAT) | 21.50 | 15.25 | 12.28 | 12.35 | 10.13 |
| PAT Growth (%) | 40.99 | 24.16 | -0.57 | 21.90 | 60.11 |
| EBIT Margin (%) | 26.88 | 26.10 | 20.62 | 20.97 | 17.00 |
| Net Profit Margin (%) | 23.58 | 17.85 | 14.89 | 15.40 | 12.27 |
| Basic EPS (₹) | 9.65 | 6.88 | 5.54 | 5.58 | 4.57 |
All figures in Rs Cr, unless mentioned otherwise
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 11.48%, which is highest in the last 3 years. (Source: Standalone Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 19.54% outperformed its 3 year CAGR of 9.23%. (Source: Standalone Financials)| Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total Assets | 400.05 | 362.33 | 307.20 | 274.36 |
| Total Assets Growth (%) | 10.41 | 17.95 | 11.97 | 11.63 |
| Total Liabilities | 80.36 | 80.54 | 73.21 | 79.98 |
| Total Liabilities Growth (%) | -0.23 | 10.00 | -8.45 | 9.72 |
| Total Equity | 319.70 | 281.79 | 233.98 | 194.38 |
| Total Equity Growth (%) | 13.45 | 20.43 | 20.37 | 12.44 |
| Current Ratio (x) | 2.91 | 2.86 | 2.60 | 2.05 |
| Total Debt to Equity (x) | 0.06 | 0.05 | 0.08 | 0.12 |
| Contingent Liabilities | 39.63 | 9.52 | 4.26 | 12.28 |
All figures in Rs Cr, unless mentioned otherwise
Contingent Liabilities Coverage
Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)| Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Net Cash flow from Operating Activities | 60.89 | 87.94 | 59.07 | 37.18 |
| Net Cash used in Investing Activities | -76.05 | -57.26 | -37.85 | -31.92 |
| Net Cash flow from Financing Activities | -1.90 | -10.98 | -16.61 | -4.57 |
| Net Cash Flow | -17.06 | 19.70 | 4.61 | 0.69 |
| Closing Cash & Cash Equivalent | 13.44 | 30.50 | 10.80 | 6.19 |
| Closing Cash & Cash Equivalent Growth (%) | -55.93 | 182.41 | 74.39 | 12.50 |
| Total Debt/ CFO (x) | 0.32 | 0.17 | 0.33 | 0.62 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 129.67 cr for investing activities which is an YoY increase of 71.66%. (Source: Standalone Financials)| Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Return on Equity (%) | 12.82 | 17.09 | 17.66 | 11.01 |
| Return on Capital Employed (%) | 16.36 | 22.17 | 22.51 | 13.92 |
| Return on Assets (%) | 10.25 | 13.29 | 13.45 | 7.80 |
| Interest Coverage Ratio (x) | 42.79 | 37.19 | 54.56 | 24.81 |
| Asset Turnover Ratio (x) | 0.83 | 0.95 | 0.96 | 0.81 |
| Price to Earnings (x) | 24.04 | 14.45 | 16.86 | 16.64 |
| Price to Book (x) | 3.08 | 2.47 | 2.98 | 1.83 |
| EV/EBITDA (x) | 10.78 | 6.82 | 8.62 | 6.92 |
| EBITDA Margin (%) | 28.52 | 30.91 | 29.37 | 25.52 |
Found Financials useful?
No Data Available
No Data Available
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
MF Ownership as on 31 May 2026
0.02
Amount Invested (in Cr.)
0.05%
% of AUM
-9.51
% Change (MoM basis)
0.01
Amount Invested (in Cr.)
0.05%
% of AUM
6.63
% Change (MoM basis)
General Meeting
-
May 06, 2026
Final
100%
May 06, 2026
Board Meeting
Audited Results & Final Dividend
Apr 29, 2026
| Announced on | Meeting on |
| Apr 29, 2026 | May 06, 2026 |
| Audited Results & Final Dividend | |
| Jan 21, 2026 | Jan 28, 2026 |
| Quarterly Results | |
| Oct 28, 2025 | Nov 03, 2025 |
| Quarterly Results | |
| Jul 14, 2025 | Jul 17, 2025 |
| Quarterly Results | |
| Jun 13, 2025 | Jun 14, 2025 |
| Others | |
| Announced on | Ex-Date | Dividend% |
| May 06, 2026 | Jun 18, 2026 | 100% |
| Apr 28, 2025 | May 30, 2025 | 100% |
| May 21, 2024 | Jul 11, 2024 | 100% |
| May 03, 2023 | Jun 21, 2023 | 100% |
| May 12, 2022 | Jun 16, 2022 | 100% |
| Announced on | Ex-Date |
| Apr 28, 2025 | Jun 13, 2025 |
| Bonus Ratio: 1 share(s) for every 1 shares held | |
| Announced on | Ex-Date |
| Jan 09, 2006 | Feb 24, 2006 |
| Split: Old FV10.0| New FV:2.0 | |
No Data Available
| Announced on | Meeting on |
| May 06, 2026 | Jun 25, 2026 |
| - | |
| May 15, 2025 | Jun 06, 2025 |
| - | |
| May 21, 2024 | Jul 18, 2024 |
| Book closure from Jul 12, 2024 to Jul 18, 2024 | |
| Feb 23, 2024 | Mar 28, 2024 |
| - | |
| Jun 01, 2023 | Jun 28, 2023 |
| Rs.2.0000 per share(100%)Final Dividend & A.G.M. | |
Vimta Labs Ltd., incorporated in the year 1990, is a Small Cap company (having a market cap of Rs 2,438.95 Crore) operating in Miscellaneous sector.
Industry
Key Indices Listed On
BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap
Address
Plot Nos. 141/2 & 142,IDA Phase II, Cherlapally,Hyderabad, Telangana - 500051
Sivalinga Prasad Vasireddi
Executive ChairmanHarita Vasireddi
Managing DirectorHarriman Vungal
Executive Director - OperationsSatya Sreenivas Neerukonda
Executive DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.